These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8866184)

  • 1. Clinical mycobacteriology. Drug susceptibility testing.
    Heifets LB
    Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of multiple drug-resistance between Mycobacterium avium complex and Mycobacterium fortuitum and Mycobacterium chelonae].
    Tsukamura M
    Kekkaku; 1988 Aug; 63(8):563-8. PubMed ID: 3184587
    [No Abstract]   [Full Text] [Related]  

  • 4. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. College of American Pathologists Mycobacteriology E Proficiency Testing Survey. Summary of participant performance, 1979-1992.
    Woods GL; Witebsky FG
    Arch Pathol Lab Med; 1995 Jan; 119(1):17-22. PubMed ID: 7802547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of antimicrobial agents against mycobacteria.
    Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R
    Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistance in M. tuberculosis and other mycobacteria.
    David HL
    Clin Chest Med; 1980 May; 1(2):227-30. PubMed ID: 6794975
    [No Abstract]   [Full Text] [Related]  

  • 10. Single and double drug susceptibility testing of Mycobacterium avium complex and mycobacteria other than the tubercle (MOTT) bacilli by a micro-dilution broth minimum inhibitory concentration (MIC) method.
    Telles MA; Yates MD
    Tuber Lung Dis; 1994 Aug; 75(4):286-90. PubMed ID: 7949075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cross-resistance relationship between streptomycin and kanamycin resistances in Mycobacterium smegmatis (strain Jucho)--comparison of the development patterns of resistances to streptomycin and kanamycin among Mycobacterium tuberculosis, Mycobacterium avium complex, and Mycobacterium smegmatis].
    Tsukamura M
    Kekkaku; 1990 Dec; 65(12):785-9. PubMed ID: 2127614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Currently used laboratory methods for testing the sensitivity and resistance of mycobacteria to drugs. Usefulness and limitations (author's transl)].
    Simon-Pouthier F
    Acta Tuberc Pneumol Belg; 1972; 63(4):399-404. PubMed ID: 4206437
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N
    Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
    Tsukamura M
    Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of mycobacterial isolates from AIDS patients.
    Scavizzi A; Baldelli F; Capparelli G; Merletti L; Pasticci MB; Polidori M; Tascini C; Sbaraglia G
    J Chemother; 1995 Nov; 7 Suppl 4():87-9. PubMed ID: 8904118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance to antitubercular drugs of atypical Mycobacterium pathogenic to man].
    Casal Román M
    Rev Clin Esp; 1978 Feb; 148(4):343-5. PubMed ID: 653055
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria.
    Riska PF; Jacobs WR
    Methods Mol Biol; 1998; 101():431-55. PubMed ID: 9921495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.